Angiotensin II

Angiotensin II peptide regulates blood pressure and vascular constriction. Purchase this synthetic research peptide to support cardiovascular and renal function studies.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
Angiotensin II(CAS 68521-88-0)

CAT No: HB00117

CAS No:68521-88-0

Synonyms/Alias:ANGIOTENSIN II;4474-91-3;Angiotensin II human;Hypertensin;Human angiotensin II;Angiotensin II (human);Ang II;5-L-Isoleucineangiotensin II;Angiotensin II, human;5-Isoleucine-angiotensin II;Angiotensin II (mouse);Giapreza;Asp-Arg-Val-Tyr-Ile-His-Pro-Phe;1-8-Angiotensin I;Ile(5)-angiotensin II;Isoleucine5-angiotensin II;CHEBI:2719;Delivert;angiotensine II;ANG-(1-8)Octapeptide;isoleucine(5)-angiotensin II;UNII-M089EFU921;DRVYIHPF;Ile5-angiotensin II;Angiotensin II, 5-L-isoleucine-;1-L-Aspasaginyl-5-L-valyl angiotensin octapeptide;Angiotensin II (human type);CHEMBL408403;LJPC-501;Angiotensinum II;Angiotensin II acetate salt;L-alpha-aspartyl-L-arginyl-L-valyl-L-tyrosyl-L-isoleucyl-L-histidyl-L-prolyl-L-phenylalanine;L-Phenylalanine, N-(1-(N-(N-(N-(N-(N2-L-alpha-aspartyl-L-arginyl)-L-valyl)-L-tyrosyl)-L-isoleucyl)-L-histidyl)-L-prolyl)-;N-(1-(N-(N-(N-(N-(N(2)-L-alpha-aspartyl-L-arginyl)-L-valyl)-L-tyrosyl)-L-isoleucyl)-L-histidyl)-L-prolyl)-L-phenylalanine;(2S,5S,8S,11S,14S,17S)-2-((1H-imidazol-5-yl)methyl)-17-amino-5-((S)-sec-butyl)-1-((S)-2-(((S)-1-carboxy-2-phenylethyl)carbamoyl)pyrrolidin-1-yl)-14-(3-((diaminomethylene)amino)propyl)-8-(4-hydroxybenzyl)-11-isopropyl-1,4,7,10,13,16-hexaoxo-3,6,9,12,15-pentaazanonadecan-19-oic acid;(3S)-3-AMINO-3-{[(1S)-4-CARBAMIMIDAMIDO-1-{[(1S)-1-{[(1S)-1-{[(1S,2S)-1-{[(2S)-1-[(2S)-2-{[(1S)-1-CARBOXY-2-PHENYLETHYL]CARBAMOYL}PYRROLIDIN-1-YL]-3-(1H-IMIDAZOL-4-YL)-1-OXOPROPAN-2-YL]CARBAMOYL}-2-METHYLBUTYL]CARBAMOYL}-2-(4-HYDROXYPHENYL)ETHYL]CARBAMOYL}-2-METHYLPROPYL]CARBAMOYL}BUTYL]CARBAMOYL}PROPANOIC ACID;Alanine, N-(1-(N-(N-(N-(N-(N2-L-alpha-aspartyl-L-arginyl)-L-valyl)-L-tyrosyl)-L-isoleucyl)-L-histidyl)-L-prolyl)-3-phenyl-, L-;Angiotensinum II (INN-Latin);Angiotensin cento, human;Angiotensina II (INN-Spanish);Angiotensin II, ile(5)-;Angiotensin ii [INN:JAN];Angiotensin 2;Angiotensin-(1-8) Octapeptide;Delivert (TN);C50H71N13O12;Angiotensin II heavy;Angiotensin II (9CI);Angiotensin II (USAN);ANGIOTENSIN II,HUMAN;SCHEMBL1189;Angiotensin II (acetate);Ang II (acetate);DRVYIHPF (acetate);GTPL2504;SCHEMBL9013957;DTXSID4036778;SCHEMBL20502357;CHEBI:48432;C01CX09;DTXSID30196288;CHEBI:131170;ty-10721;M089EFU921;Angiotensin II (human type) (JAN);BDBM50228195;BDBM50236697;HB3488;AKOS016010178;DB11842;FA73187;NCGC00167130-01;DA-70862;HY-13948;NS00074073;Asp1-Arg2-Val3-Tyr4-Ile5-His6-Pro7-Phe8;C02135;C75211;D02014;DRVY-I*-HPF [I*= I(13C6,15N)];EN300-19742056;Q412999;32044-01-2, 4474-91-3 (salt);ANG-(1-8)Octapeptide, Hypertensin, 4474-91-3, Giapreza;Conalbumin (328-332), 1226776-54-0, RVPSL peptide;ProteoMass(TM) Angiotensin II MALDI-MS Standard, vial of 10 nmol;(2S,5S,8S,11S,14S,17S)-2-((1H-imidazol-4-yl)methyl)-17-amino-5-((S)-sec-butyl)-1-((S)-2-(((S)-1-carboxy-2-phenylethyl)carbamoyl)pyrrolidin-1-yl)-14-(3-guanidinopropyl)-8-(4-hydroxybenzyl)-11-isopropyl-1,4,7,10,13,16-hexaoxo-3,6,9,12,15-pentaazanonadecan-19-oic acid;(3S)-3-amino-3-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S,2S)-1-{[(2S)-1-[(2S)-2-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}pyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]carbamoyl}-2-methylbutyl]carbamoyl}-2-(4-hydroxyphenyl)ethyl]carbamoyl}-2-methylpropyl]carbamoyl}-4-[(diaminomethylidene)amino]butyl]carbamoyl}propanoic acid;L-phenylalanine, L-alpha-aspartyl-L-arginyl-L-valyl-L-tyrosyl-L-isoleucyl-L-histidyl-L-prolyl-;

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C50H71N13O12
M.W/Mr.
1046.2
Sequence
One Letter Code:DRVYIHPF
Three Letter Code:H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-OH
Source#
Synthetic
Shipping Condition
Room temperature in continental US; may vary elsewhere.
InChI
InChI=1S/C50H71N13O12/c1-5-28(4)41(47(72)59-36(23-31-25-54-26-56-31)48(73)63-20-10-14-38(63)45(70)60-37(49(74)75)22-29-11-7-6-8-12-29)62-44(69)35(21-30-15-17-32(64)18-16-30)58-46(71)40(27(2)3)61-43(68)34(13-9-19-55-50(52)53)57-42(67)33(51)24-39(65)66/h6-8,11-12,15-18,25-28,33-38,40-41,64H,5,9-10,13-14,19-24,51H2,1-4H3,(H,54,56)(H,57,67)(H,58,71)(H,59,72)(H,60,70)(H,61,68)(H,62,69)(H,65,66)(H,74,75)(H4,52,53,55)/t28-,33-,34-,35-,36-,37-,38-,40-,41-/m0/s1
InChI Key
CZGUSIXMZVURDU-JZXHSEFVSA-N

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide CDMOPeptide Analysis ServicesPeptide Synthesis ServicesCustom Conjugation ServicePeptide Modification ServicescGMP Peptide ServiceEpitope Mapping ServicesPeptide Nucleic Acids Synthesis
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers